https://investors.maravai.com/ https://investors.maravai.com/news-events/press-releases https://investors.maravai.com/news-events/ir-calendar https://investors.maravai.com/news-events/presentations https://investors.maravai.com/news-events/email-alerts https://investors.maravai.com/company-information https://investors.maravai.com/company-information/leadership https://investors.maravai.com/company-information/annual-reports-proxy https://investors.maravai.com/company-information/contacts https://investors.maravai.com/company-information/faq https://investors.maravai.com/company-information/analyst-coverage https://investors.maravai.com/financial-information/financial-results https://investors.maravai.com/financial-information/income-statement https://investors.maravai.com/financial-information/balance-sheet https://investors.maravai.com/financial-information/cash-flow https://investors.maravai.com/sec-filings/all-sec-filings https://investors.maravai.com/sec-filings/annual-reports https://investors.maravai.com/sec-filings/quarterly-reports https://investors.maravai.com/sec-filings/section-16-filings https://investors.maravai.com/sustainability https://investors.maravai.com/corporate-governance https://investors.maravai.com/corporate-governance/board-of-directors https://investors.maravai.com/corporate-governance/board-committees https://investors.maravai.com/corporate-governance/governance-documents https://investors.maravai.com/corporate-governance/whistleblower-policy https://investors.maravai.com/news-events/press-releases/detail/123/maravai-lifesciences-reports-fourth-quarter-and-full-year-2025-financial-results https://investors.maravai.com/news-events/press-releases/detail/122/maravai-lifesciences-to-host-earnings-conference-call-on-wednesday-february-25-2026 https://investors.maravai.com/news-events/press-releases/detail/121/maravai-lifesciences-announces-november-2025-investor-conference-schedule https://investors.maravai.com/news-events/press-releases/detail/120/maravai-lifesciences-reports-third-quarter-2025-financial-results https://investors.maravai.com/news-events/press-releases/detail/119/maravai-lifesciences-to-host-earnings-conference-call-on-thursday-november-6-2025 https://investors.maravai.com/news-events/press-releases/detail/118/maravai-lifesciences-reports-second-quarter-2025-financial-results https://investors.maravai.com/news-events/press-releases/detail/117/maravai-lifesciences-to-host-earnings-conference-call-on-monday-august-11-2025 https://investors.maravai.com/news-events/press-releases/detail/116/maravai-lifesciences-appoints-rajesh-asarpota-as-chief-financial-officer https://investors.maravai.com/news-events/press-releases/detail/115/maravai-lifesciences-appoints-bernd-brust-as-chief-executive-officer-and-member-of-its-board-of-directors https://investors.maravai.com/news-events/press-releases/detail/113/maravai-lifesciences-releases-2024-sustainability-report https://investors.maravai.com/news-events/press-releases/detail/112/trilink-biotechnologies-debuts-its-first-mrna-synthesis-kit-with-cleancap-capping-technology-celebrates-launch-with-kit-donations-to-top-academic-institutions https://investors.maravai.com/news-events/press-releases/detail/111/maravai-lifesciences-reports-first-quarter-2025-financial-results https://investors.maravai.com/news-events/press-releases/detail/110/maravai-lifesciences-to-host-earnings-conference-call-on-monday-may-12-2025 https://investors.maravai.com/news-events/press-releases/detail/109/maravai-lifesciences-reports-fourth-quarter-and-full-year-2024-financial-results https://investors.maravai.com/news-events/press-releases/detail/108/maravai-lifesciences-postpones-its-fourth-quarter-and-full-year-2024-earnings-release-and-conference-call https://investors.maravai.com/news-events/press-releases/detail/107/trilink-biotechnologies-partners-with-avantor-to-expand-nucleic-acid-solutions-in-europe https://investors.maravai.com/news-events/press-releases/detail/106/maravai-lifesciences-acquires-assets-and-intellectual-property-from-molecular-assemblies https://investors.maravai.com/news-events/press-releases/detail/105/maravai-lifesciences-announces-preliminary-unaudited-2024-revenue https://investors.maravai.com/news-events/press-releases/detail/104/maravai-lifesciences-appoints-r-andrew-eckert-as-chairman-of-the-board-of-directors https://investors.maravai.com/news-events/press-releases/detail/103/maravai-lifesciences-announces-november-2024-investor-conference-schedule https://investors.maravai.com/news-events/press-releases/detail/102/maravai-lifesciences-plans-to-acquire-dna-and-rna-business-of-officinae-bio-advancing-support-for-innovative-nucleic-acid-research https://investors.maravai.com/news-events/press-releases/detail/101/maravai-lifesciences-reports-third-quarter-2024-financial-results https://investors.maravai.com/news-events/press-releases/detail/100/maravai-lifesciences-to-host-earnings-conference-call-on-thursday-november-7-2024 https://investors.maravai.com/news-events/press-releases/detail/99/trilink-biotechnologies-alphazyme-collaborate-to-launch-new-cleanscribe-rna-polymerase https://investors.maravai.com/news-events/press-releases/detail/98/cygnus-technologies-and-trilink-biotechnologies-collaborate-to-launch-accures-host-cell-dna-quantification-kits https://investors.maravai.com/news-events/press-releases/detail/97/maravai-lifesciences-announces-august-and-september-2024-investor-conference-schedule https://investors.maravai.com/news-events/press-releases/detail/96/maravai-lifesciences-reports-second-quarter-2024-financial-results https://investors.maravai.com/news-events/press-releases/detail/95/maravai-lifesciences-appoints-trey-martin-to-board-of-directors https://investors.maravai.com/news-events/press-releases/detail/94/maravai-lifesciences-to-host-earnings-conference-call-on-wednesday-august-7-2024 https://investors.maravai.com/news-events/press-releases/detail/93/maravai-lifesciences-releases-2023-environmental-social-and-governance-esg-report https://investors.maravai.com/news-events/press-releases/detail/92/applied-dna-and-alphazyme-conclude-lineatm-rnap-manufacturing-scale-up-project-deliver-substantial-improvement-in-lineatm-ivt-platform-economics https://investors.maravai.com/news-events/press-releases/detail/91/trilink-biotechnologies-collaborates-with-johns-hopkins-university-to-establish-a-new-rna-innovation-center https://investors.maravai.com/news-events/press-releases/detail/90/maravai-lifesciences-announces-may-and-june-2024-investor-conference-schedule https://investors.maravai.com/news-events/press-releases/detail/89/maravai-lifesciences-reports-first-quarter-2024-financial-results https://investors.maravai.com/news-events/press-releases/detail/88/trilink-biotechnologies-and-lonza-enter-into-non-exclusive-license-and-supply-agreement-for-cleancap-mrna-capping-technology https://investors.maravai.com/news-events/press-releases/detail/87/trilink-biotechnologies-announces-new-san-diego-facility-for-late-phase-mrna-drug-substance-production https://investors.maravai.com/news-events/press-releases/detail/86/maravai-lifesciences-to-host-earnings-conference-call-on-wednesday-may-8-2024 https://investors.maravai.com/news-events/press-releases/detail/85/applied-dna-enters-into-agreement-with-alphazyme-for-scale-up-manufacturing-of-its-proprietary-lineatm-rnap-progresses-towards-gmp-lineatm-ivt-production-start https://investors.maravai.com/news-events/press-releases/detail/84/maravai-lifesciences-announces-march-2024-investor-conference-schedule https://investors.maravai.com/news-events/press-releases/detail/83/maravai-lifesciences-reports-fourth-quarter-and-full-year-2023-financial-results https://investors.maravai.com/news-events/press-releases/detail/82/trilink-biotechnologies-solidifies-ip-position-with-awarded-patents-for-cleancap-capping-technology-in-china-and-canada https://investors.maravai.com/news-events/press-releases/detail/81/dyadic-and-cygnus-technologies-announce-partnership-to-provide-c1-hcp-elisa-assay-to-enhance-quality-assurance-in-biomanufacturing https://investors.maravai.com/news-events/press-releases/detail/80/maravai-lifesciences-to-host-earnings-conference-call-on-thursday-february-22-2024 https://investors.maravai.com/news-events/press-releases/detail/79/maravai-lifesciences-announces-november-2023-investor-conference-schedule https://investors.maravai.com/news-events/press-releases/detail/78/maravai-lifesciences-reports-third-quarter-2023-financial-results https://investors.maravai.com/news-events/press-releases/detail/76/trilink-biotechnologies-expands-capabilities-with-launch-of-analytical-sciences-center-of-excellence https://investors.maravai.com/news-events/press-releases/detail/77/trilink-biotechnologies-and-intellia-sign-multiyear-supply-agreement https://investors.maravai.com/news-events/press-releases/detail/75/maravai-lifesciences-to-host-earnings-conference-call-on-tuesday-november-7-2023 https://investors.maravai.com/news-events/press-releases/detail/74/maravai-lifesciences-hosts-2023-investor-rd-day https://investors.maravai.com/news-events/press-releases/detail/73/maravai-lifesciences-chief-innovation-officer-kate-broderick-named-to-2023-pharmavoice-100 https://investors.maravai.com/news-events/press-releases/detail/72/maravai-lifesciences-to-host-2023-investor-rd-day https://investors.maravai.com/news-events/press-releases/detail/71/cygnus-technologies-receives-2023-rd-100-award-for-mockv-rvlp-kit https://investors.maravai.com/news-events/press-releases/detail/70/maravai-lifesciences-announces-august-2023-investor-conference-schedule https://investors.maravai.com/news-events/press-releases/detail/69/maravai-lifesciences-reports-second-quarter-2023-financial-results https://investors.maravai.com/news-events/press-releases/detail/68/maravai-lifesciences-announces-completion-of-planned-ceo-leadership-transition https://investors.maravai.com/news-events/press-releases/detail/67/maravai-lifesciences-to-host-earnings-conference-call-on-monday-august-7-2023 https://investors.maravai.com/news-events/press-releases/detail/66/maravai-lifesciences-announces-appointment-of-new-director-to-the-board https://investors.maravai.com/news-events/press-releases/detail/65/congressman-scott-peters-tours-maravais-rna-manufacturing-facility https://investors.maravai.com/news-events/press-releases/detail/64/trilink-biotechnologies-introduces-latest-mrna-capping-technology-cleancap-m6-analog https://investors.maravai.com/news-events/press-releases/detail/63/maravai-lifesciences-reports-first-quarter-2023-financial-results https://investors.maravai.com/news-events/press-releases/detail/62/maravai-lifesciences-to-host-earnings-conference-call-on-monday-may-8-2023 https://investors.maravai.com/news-events/press-releases/detail/61/maravai-lifesciences-releases-2022-environmental-social-and-governance-esg-report https://investors.maravai.com/news-events/press-releases/detail/60/maravai-lifesciences-announces-march-2023-investor-conference-schedule https://investors.maravai.com/news-events/press-releases/detail/59/maravai-lifesciences-reports-fourth-quarter-and-full-year-2022-financial-results https://investors.maravai.com/news-events/press-releases/detail/58/maravai-lifesciences-to-host-earnings-conference-call-on-wednesday-february-22-2023 https://investors.maravai.com/news-events/press-releases/detail/57/maravai-lifesciences-announces-updated-ceo-leadership-transition-plans https://investors.maravai.com/news-events/press-releases/detail/56/maravai-lifesciences-named-to-the-2022-deloitte-technology-fast-500-list-of-fastest-growing-companies-in-north-america https://investors.maravai.com/news-events/press-releases/detail/55/new-kit-predicts-retroviral-particle-clearance-in-biopharmaceutical-manufacturing https://investors.maravai.com/news-events/press-releases/detail/54/maravai-lifesciences-announces-november-and-december-2022-investor-conference-schedule https://investors.maravai.com/news-events/press-releases/detail/53/maravai-lifesciences-reports-third-quarter-2022-financial-results https://investors.maravai.com/news-events/press-releases/detail/52/maravai-lifesciences-temporarily-reinstates-carl-hull-as-ceo-amidst-pending-noncompetition-litigation https://investors.maravai.com/news-events/press-releases/detail/51/maravai-lifesciences-to-host-earnings-conference-call-on-wednesday-november-2-2022 https://investors.maravai.com/news-events/press-releases/detail/5/maravai-lifesciences-announces-ceo-leadership-transition https://investors.maravai.com/news-events/press-releases/detail/6/trilink-biotechnologies-part-of-maravai-lifesciences-expands-its-mrna-raw-material-offering-with-the-first-gmp-grade-modified-nucleoside-triphosphate-product https://investors.maravai.com/news-events/press-releases/detail/7/maravai-lifesciences-announces-september-2022-investor-conference-schedule https://investors.maravai.com/news-events/press-releases/detail/8/maravai-lifesciences-reports-second-quarter-2022-financial-results https://investors.maravai.com/news-events/press-releases/detail/10/maravai-lifesciences-to-host-earnings-conference-call-on-thursday-august-4-2022 https://investors.maravai.com/news-events/press-releases/detail/11/trilink-biotechnologies-part-of-maravai-lifesciences-expands-rd-leadership-team https://investors.maravai.com/news-events/press-releases/detail/12/maravai-lifesciences-strengthens-executive-leadership-team-to-support-long-term-growth https://investors.maravai.com/news-events/press-releases/detail/13/trilink-biotechnologies-part-of-maravai-lifesciences-announces-cooperative-agreement-with-department-of-defense https://investors.maravai.com/news-events/press-releases/detail/14/maravai-lifesciences-announces-may-and-june-2022-investor-conference-schedule https://investors.maravai.com/news-events/press-releases/detail/15/maravai-lifesciences-reports-first-quarter-2022-financial-results https://investors.maravai.com/news-events/press-releases/detail/16/maravai-lifesciences-to-host-earnings-conference-call-on-thursday-may-5-2022 https://investors.maravai.com/news-events/press-releases/detail/17/maravai-lifesciences-announces-march-2022-investor-conference-schedule https://investors.maravai.com/news-events/press-releases/detail/18/maravai-lifesciences-reports-fourth-quarter-and-full-year-2021-financial-results-and-updates-2022-financial-guidance https://investors.maravai.com/news-events/press-releases/detail/19/maravai-lifesciences-acquires-mychem-a-leader-in-proprietary-ultra-pure-nucleotides https://investors.maravai.com/news-events/press-releases/detail/20/maravai-lifesciences-announces-upcoming-investor-events https://investors.maravai.com/news-events/press-releases/detail/21/maravai-lifesciences-announces-debt-repricing https://investors.maravai.com/news-events/press-releases/detail/22/maravai-lifesciences-announces-registration-and-webcast-information-for-upcoming-rd-day-to-be-held-on-january-28-2022 https://investors.maravai.com/news-events/press-releases/detail/23/maravai-lifesciences-added-to-the-nasdaq-biotechnology-index https://investors.maravai.com/news-events/press-releases/detail/24/maravai-lifesciences-announces-establishment-of-new-charitable-foundation https://investors.maravai.com/news-events/press-releases/detail/25/maravai-lifesciences-reports-third-quarter-financial-results-updates-2021-financial-guidance-and-provides-preliminary-revenue-guidance-for-2022 https://investors.maravai.com/news-events/press-releases/detail/26/maravai-lifesciences-announces-november-2021-investor-conference-schedule https://investors.maravai.com/news-events/press-releases/detail/27/maravai-lifesciences-to-host-earnings-conference-call-on-wednesday-november-10-2021 https://investors.maravai.com/news-events/press-releases/detail/28/maravai-lifesciences-expands-its-intellectual-property-portfolio-with-european-patent https://investors.maravai.com/news-events/press-releases/detail/29/trilink-biotechnologies-extends-eyegene-partnership-for-covid-19-vaccine-development-in-south-korea https://investors.maravai.com/news-events/press-releases/detail/30/maravai-lifesciences-announces-pricing-of-secondary-offering-of-class-a-common-stock-by-selling-stockholders https://investors.maravai.com/news-events/press-releases/detail/31/maravai-lifesciences-announces-launch-of-proposed-secondary-offering-of-class-a-common-stock-by-selling-stockholders https://investors.maravai.com/news-events/press-releases/detail/32/maravai-lifesciences-announces-september-2021-investor-conference-schedule https://investors.maravai.com/news-events/press-releases/detail/33/maravai-lifesciences-reports-second-quarter-financial-results-and-updates-2021-financial-guidance https://investors.maravai.com/news-events/press-releases/detail/34/trilink-biotechnologies-extends-global-support-of-covid-19-vaccine-development-into-apac-region-with-the-chula-vaccine-research-center-chula-vrc-bangkok https://investors.maravai.com/news-events/press-releases/detail/35/maravai-lifesciences-to-host-earnings-conference-call-on-tuesday-august-10-2021 https://investors.maravai.com/news-events/press-releases/detail/36/maravai-lifesciences-announces-june-2021-investor-conference-schedule https://investors.maravai.com/news-events/press-releases/detail/37/maravai-lifesciences-reports-first-quarter-financial-results-and-updates-2021-financial-guidance https://investors.maravai.com/news-events/press-releases/detail/38/maravai-lifesciences-announces-investor-conference-schedule-for-the-month-of-may-2021 https://investors.maravai.com/news-events/press-releases/detail/39/maravai-lifesciences-to-host-earnings-conference-call-on-monday-may-10-2021 https://investors.maravai.com/news-events/press-releases/detail/40/maravai-lifesciences-announces-closing-of-secondary-offering-of-class-a-common-stock-by-selling-stockholders-and-full-exercise-of-the-underwriters-option-to-purchase-additional-shares https://investors.maravai.com/news-events/press-releases/detail/41/maravai-lifesciences-announces-pricing-of-an-upsized-secondary-offeringof-class-a-common-stock-by-selling-stockholders https://investors.maravai.com/news-events/press-releases/detail/42/maravai-lifesciences-announces-launch-of-proposed-secondary-offeringof-class-a-common-stock-by-selling-stockholders https://investors.maravai.com/news-events/press-releases/detail/43/maravai-lifesciences-announces-preliminary-unaudited-first-quarter-revenues-and-income-from-operations-range https://investors.maravai.com/news-events/press-releases/detail/44/maravai-lifesciences-offers-end-to-end-mrna-production-with-the-launch-of-trilink-biotechnologies-plasmid-dna-manufacturing-services https://investors.maravai.com/news-events/press-releases/detail/45/maravai-lifesciences-reports-fourth-quarter-and-full-year-2020-financial-results-and-initiates-2021-financial-guidance https://investors.maravai.com/news-events/press-releases/detail/46/maravai-lifesciences-announces-march-2021-investor-conference-schedule https://investors.maravai.com/news-events/press-releases/detail/47/maravai-lifesciences-expands-its-intellectual-property-portfolio https://investors.maravai.com/news-events/press-releases/detail/48/maravai-lifesciences-to-host-earnings-conference-call-on-tuesday-march-2-2021 https://investors.maravai.com/news-events/press-releases/detail/49/maravai-lifesciences-announces-closing-of-initial-public-offering-and-full-exercise-of-the-underwriters-option-to-purchase-additional-shares https://investors.maravai.com/news-events/press-releases/detail/50/maravai-lifesciences-announces-pricing-of-an-upsized-initial-public-offering https://investors.maravai.com/privacy-policy https://investors.maravai.com/disclaimer https://investors.maravai.com/sitemap